A Rare Cutaneous Manifestation of Immune Checkpoint Inhibitor Therapy
CLINICAL CASE REPORTS(2023)
摘要
Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions-such as Stevens-Johnson syndrome, erythema multiforme, and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome-is crucial for guiding management.
更多查看译文
关键词
Immune checkpoint inhibitor,leukoclastic vasculitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要